BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181016
DTEND;VALUE=DATE:20181020
DTSTAMP:20260526T042055
CREATED:20180531T100732Z
LAST-MODIFIED:20181003T124915Z
UID:7469-1539648000-1539993599@www.afssi.fr
SUMMARY:26th Annual Congress of the ESGCT
DESCRIPTION:ESGCT organises an Annual Congress\, which brings together scientists working in the fields of gene and cell therapy from throughout Europe and beyond. The Congress is typically held in October or November in a major European city. The Congress is a platform for highlighting the latest research and techniques through the scientific sessions\, which include keynote lectures\, invited speakers\, selected speakers\, poster sessions and exhibitions. \nFurthermore\, the Congress is an opportunity to develop relationships and collaborations. The public day\, where key concepts in gene and cell therapy along with the latest research are presented in the local language to a general audience\, is an integral part of the Congress. The Congress may be organised solely by ESGCT\, but is often organised in collaboration with a national society for gene and cell therapy in Europe\, for example the German Society for Gene Therapy (DG-GT) in 2017\, or with closely related scientific societies\, such as the International Society for Stem Cell Research (ISSCR) in 2016 and 2018.
URL:https://www.afssi.fr/event/26th-annual-congress-esgct/
LOCATION:SwissTech Convention Center\, Route Louis-Favre 2\, Lausanne\, Suisse
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2018/05/event-26th-Annual-Congress-of-the-ESGCT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181018
DTEND;VALUE=DATE:20181020
DTSTAMP:20260526T042055
CREATED:20180927T122144Z
LAST-MODIFIED:20180927T123027Z
UID:8085-1539820800-1539993599@www.afssi.fr
SUMMARY:4th International Conference on Synthetic Biology and Tissue Engineering
DESCRIPTION:Tissue engineering is aimed mainly at producing anatomically and physiologically realistic replacements for normal human tissues. Synthetic biology is aimed mainly at engineering cells so that they can perform custom functions: applying synthetic biological approaches to tissue engineering may be one way of engineering custom structures. \nTheme: Design and construct new biological parts for novel functions\nAbout Conference\n\nConferenceseries Ltd International Conferences invites all the participants from all over the world to attend « 4thInternational Conference on Synthetic Biology and Tissue Engineering » during June 11-12\, 2018 at Rome\, Italy\, which includes prompt keynote presentations\, Oral talks\, Poster presentations and Exhibitions.\nTissue engineering is aimed mainly at producing anatomically and physiologically realistic replacements for normal human tissues. It is done either by encouraging cellular colonization of manufactured matrices or cellular recolonization of decellularized natural extracellular matrices from donor organs\, or by allowing cells to self-organize into organs as they do during fetal life. For repair of normal bodies\, this will be adequate but there are reasons for making unusual\, non-evolved tissues (repair of unusual bodies\, interface to electromechanical prostheses\, and incorporating living cells into life-support machines).\nSynthetic biology is aimed mainly at engineering cells so that they can perform custom functions: applying synthetic biological approaches to tissue engineering may be one way of engineering custom structures. The embryological cycle of patterning\, differentiation and morphogenesis and review progress that has been made in constructing synthetic biological systems to reproduce these processes in new ways. The state-of-the-art remains a long way from making truly synthetic tissues\, but there are now at least foundations for future work. Scientifically\, the success of these endeavors is the ultimate proof that we know enough about cellular signaling pathways to harness them for our purposes. From a practical standpoint\, targeted regulation of cell signaling paves the way to real cures of many disorders\, genetic and acquired\, where before we could only manage the symptoms using small molecules.\n\nObjective\nSynthetic Biology and Tissue Engineering 2018 has the goal to fulfill the prevailing gaps in the transformation of this science of hope\, to serve promptly with solutions to all in the need. International Conference on Synthetic Biology and Tissue Engineering 2018 will have an anticipated participation of 150+ delegates across the world to discuss the conference goal. \nFind more information here 
URL:https://www.afssi.fr/event/4th-international-conference-on-synthetic-biology-and-tissue-engineering/
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2018/09/event-Synthetic-Biology-and-Tissue-Engineering-2018.jpg
END:VEVENT
END:VCALENDAR